Search results for " biomarker"

showing 10 items of 478 documents

Current advancement in immunosensing of p53 tumor suppressor protein based on nanomaterials: Analytical approach

2017

Abstract The utility of detection of p53 in tomorrow's personalized health care field will mean early and accurate diagnosis of many types of cancers. This review is meant to provide an overview of the various types of immunosensors and immunoassay have been developed for determination of p53, along with significant advances over the last several years in related technologies. In addition, this review described: • Most frequently applied principles in immunoassay/immunosensing of p53. • The aspects of fabrication in the perspective of immunoassay/immunosensing applications. • The potential of various electrochemical, electrochemiluminescence immunosensors for the determination of p53 within…

medicine.diagnostic_testComputer science010401 analytical chemistryNanotechnologyPersonalized health02 engineering and technology021001 nanoscience & nanotechnology01 natural sciences0104 chemical sciencesAnalytical ChemistryTumor BiomarkersImmunoassayP53 Tumor Suppressor ProteinmedicineElectrochemiluminescence0210 nano-technologySpectroscopyTrAC Trends in Analytical Chemistry
researchProduct

Multimodality imaging strategies for the assessment of aortic stenosis: Viewpoint of the heart valve clinic international database (HAVEC) group

2016

International audience; Aortic stenosis is the most frequent valvular heart disease. In aortic stenosis, therapeutic decision essentially depends on symptomatic status, stenosis severity, and status of left ventricular systolic function. Surgical aortic valve replacement or transcatheter aortic valve implantation is the sole effective therapy in symptomatic patients with severe aortic stenosis, whereas the management of asymptomatic patients remains controversial and is mainly based on individual risk stratification. Imaging is fundamental for the initial diagnostic work-up, follow-up, and selection of the optimal timing and type of intervention. The present review provides specific recomme…

medicine.medical_specialty030204 cardiovascular system & hematologyDoppler echocardiographyAsymptomaticMultimodal ImagingRisk Assessment03 medical and health sciences0302 clinical medicineAortic valve replacementInternal medicinemedicineHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineHeart valvehumanaortic valve stenosis ◼ biomarkers ◼ echocardiography Doppler ◼ guideline ◼ prognosis ◼ standardsalgorithmmedicine.diagnostic_testbusiness.industrypractice guidelinevalvular heart diseaseAortic Valve Stenosismedicine.diseasebiological markerPrognosis3. Good healthStenosismedicine.anatomical_structureclassificationAortic valve stenosisPractice Guidelines as TopicCardiologycardiovascular system[SDV.IB]Life Sciences [q-bio]/BioengineeringRadiologymedicine.symptomCardiology and Cardiovascular MedicineRisk assessmentbusinessAlgorithmsBiomarkers
researchProduct

State of the Art-High-Sensitivity Troponins in Acute Coronary Syndromes.

2020

In cases of suspected acute coronary syndrome (ACS), rapid and accurate diagnosis is essential to establish effective evidence-based medical treatment. Patients' history, clinical examination, 12-lead electrocardiogram, and cardiac biomarkers are cornerstones in initial management. Since high-sensitivity cardiac troponins were established, they have markedly expedited and revolutionized rule-in and rule-out pathways of patients with ACS and changed our everyday clinical practice. Thus, they have become an indispensable tool in daily routine in emergency units. This review focuses on historical and contemporary standards in laboratory biomarkers of myocardial injury and discusses their impli…

medicine.medical_specialtyAcute coronary syndromeCardiac biomarkersMyocardial InfarctionPhysical examinationContext (language use)030204 cardiovascular system & hematologySensitivity and SpecificityDiagnosis Differential03 medical and health sciences0302 clinical medicinemedicineHumans030212 general & internal medicineMyocardial infarctionAcute Coronary SyndromeIntensive care medicinebiologymedicine.diagnostic_testMedical treatmentbusiness.industryGeneral Medicinemedicine.diseaseTroponinTroponinbiology.proteinBiomarker (medicine)Cardiology and Cardiovascular MedicinebusinessBiomarkersCardiology clinics
researchProduct

Clinical and Molecular-Genetic Insights into the Role of Oxidative Stress in Diabetic Retinopathy: Antioxidant Strategies and Future Avenues

2020

Reactive oxygen species (ROS) overproduction and ROS-signaling pathways activation attack the eyes. We evaluated the oxidative stress (OS) and the effects of a daily, core nutritional supplement regimen containing antioxidants and omega 3 fatty acids (A/ω3) in type 2 diabetics (T2DM). A case-control study was carried out in 480 participants [287 T2DM patients with (+)/without (−) diabetic retinopathy (DR) and 193 healthy controls (CG)], randomly assigned to a daily pill of A/ω3. Periodic evaluation through 38 months allowed to outline patient characteristics, DR features, and classic/OS blood parameters. Statistics were performed by the SPSS 24.0 program. Diabetics displayed significantly h…

medicine.medical_specialtyAntioxidanttype 2 diabetes mellitusPhysiologyThiobarbituric acidmedicine.medical_treatmentClinical BiochemistryDietética y nutrición030209 endocrinology & metabolismmedicine.disease_causeBiochemistryArticle03 medical and health scienceschemistry.chemical_compound0302 clinical medicineprevention of blindnessInternal medicineretinopathymedicineTBARSoxidative stressMolecular Biologyomega-3 fatty acidsVitamin Cbusiness.industrylcsh:RM1-950Cell BiologyDiabetic retinopathymedicine.diseaseMalondialdehydeAnatomía ocularlcsh:Therapeutics. PharmacologyantioxidantsEndocrinologychemistrycandidate biomarkers030221 ophthalmology & optometryOftalmologíabusinessOxidative stressRetinopathy
researchProduct

Mild cognitive impairment: A systematic review

2007

MCI is a nosological entity proposed as an intermediate state between normal aging and dementia. The syndrome can be divided into two broad subtypes: amnestic MCI ( aMCI) characterized by reduced memory, and non- amnestic MCI ( naMCI) in which other cognitive functions rather than memory are mostly impaired. aMCI seems to represent an early stage of AD, while the outcomes of the naMCI subtypes appear more heterogeneous - including vascular dementia, frontotemporal dementia or dementia with Lewy bodies- but this aspect is still under debate. MCI in fact represents a condition with multiple sources of heterogeneity, including clinical presentation, etiology, and prognosis. To improve classifi…

medicine.medical_specialtyApolipoprotein E4Neuropsychological TestsSeverity of Illness Indexbehavioral disciplines and activitiesPhysical medicine and rehabilitationNeuroimagingAlzheimer DiseaseFluorodeoxyglucose F18Risk Factorsmental disordersEpidemiologySeverity of illnessmedicineHumansDementiaVascular dementiaapolipoprotein EAlzheimer disease; apolipoprotein E; biomarkers; diagnosis; mild congnitive impairmentMemory Disordersbusiness.industryDementia VascularGeneral NeuroscienceBrainCognitionGeneral Medicinemedicine.diseaseMagnetic Resonance Imagingmild congnitive impairmentdiagnosiPsychiatry and Mental healthClinical PsychologyEtiologybiomarkerSettore MED/26 - NeurologiaRadiopharmaceuticalsGeriatrics and GerontologyCognition DisordersbusinessFrontotemporal dementia
researchProduct

The Role of Imaging Biomarkers in the Assessment of Sarcopenia

2020

Background: The diagnosis of sarcopenia through clinical assessment has some limitations. The literature advises studies that include objective markers along with clinical assessment in order to improve the sensitivity and specificity of current diagnostic criteria. The decrease of muscle quality precedes the loss of quantity, so we studied the role magnetic resonance imaging biomarkers as indicators of the quantity and quality of muscle in sarcopenia patients. Methods: a cross-sectional analysis was performed to analyze what MR-derived imaging parameters correlate better with sarcopenia diagnostic criteria in women of 70 years of age and over (independent walking and community-dwelling wom…

medicine.medical_specialtyClinical BiochemistryMuscle massArticle030218 nuclear medicine & medical imagingFat massIndependent walkingsarcopeniaolder people03 medical and health sciences0302 clinical medicineInternal medicinemagnetic resonance imagingMedicineStage (cooking)lcsh:R5-920medicine.diagnostic_testbusiness.industryMagnetic resonance imagingmedicine.diseaseSpanish populationSarcopeniabiomarkerBiomarker (medicine)sarcopenia; magnetic resonance imaging; biomarker; older peoplelcsh:Medicine (General)businesshuman activities030217 neurology & neurosurgeryDiagnostics
researchProduct

The use of Alzheimer CSF biomarkers in daily clinical practice

2020

medicine.medical_specialtyEpidemiologyBehavioral neurologybusiness.industryHealth PolicyNeuropsychiatrymedicine.diseaseClinical PracticePsychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeuroscienceCsf biomarkersmedicineDementiaNeurology (clinical)Geriatrics and GerontologyPsychiatrybusinessAlzheimer's & Dementia
researchProduct

Impact of domestic mould exposure on Aspergillus biomarkers and lung function in patients with chronic obstructive pulmonary disease

2021

International audience; Patients with chronic obstructive pulmonary disease (COPD) are frequently colonised or sensitised by Aspergillus, but clinical significance remains unclear. Furthermore, little is known on the impact of indoor mould exposure during COPD. In this study, we assessed the relationship between domestic mould exposure, Aspergillus biomarkers and COPD severity during acute exacerbation and at stable state. Aspergillus section Fumigati culture in sputum and anti-Aspergillus antibodies detection (IgG and precipitins) were followed up in COPD patients that were prospectively recruited during exacerbation (n = 62), and underwent a visit at stable state after 18 months (n = 33).…

medicine.medical_specialtyExacerbationMESH: Pulmonary Disease Chronic Obstructive010501 environmental sciencesEnvironmentMESH: Forced Expiratory VolumeAspergillosis01 natural sciencesBiochemistryGastroenterologyPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineanti-Aspergillus antibodiesForced Expiratory VolumeInternal medicinemedicineAspergillosisHumansCOPDClinical significanceMESH: Lung030212 general & internal medicineMESH: AspergillosisLungLung function0105 earth and related environmental sciencesGeneral Environmental Science[SDV.EE.SANT]Life Sciences [q-bio]/Ecology environment/HealthCOPDAspergillusMESH: Humansbiologybusiness.industryFungimedicine.diseasebiology.organism_classificationrespiratory tract diseasesAspergillusMESH: Aspergillusbiology.proteinMESH: BiomarkersSputummedicine.symptomAntibodybusinessBiomarkers
researchProduct

Cardiac magnetic resonance-derived fibrosis, strain and molecular biomarkers of fibrosis in hypertensive heart disease

2020

Aims Myocardial fibrosis is a relevant component of hypertensive heart disease (HHD). Novel cardiovascular magnetic resonance (CMR) imaging techniques have shown potential in quantification of diffuse cardiac fibrosis, with T1 mapping, and estimating preclinical cardiac dysfunction, with strain analysis. Molecular biomarkers of fibrosis have been related with clinical outcomes and histologically proven myocardial fibrosis. The relationship between these CMR-imaging techniques and circulating biomarkers is not fully understood. Methods and results CMR was performed on a 3T scanner in 36 individuals with HHD. Extracellular volume fraction (ECV) and the partition coefficient were assessed usin…

medicine.medical_specialtyHeart DiseasesPhysiologyCardiac fibrosisStrain (injury)030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineFibrosisInternal medicineInternal MedicinemedicineHumans030212 general & internal medicinemedicine.diagnostic_testbusiness.industryMyocardiumHeartMagnetic resonance imagingmedicine.diseaseFibrosisMagnetic Resonance ImagingMolecular biomarkersHypertensive heart diseaseHypertensioncardiovascular systemCardiologyMyocardial fibrosisCardiology and Cardiovascular MedicineCardiac magnetic resonancebusinessJournal of Hypertension
researchProduct

Electrochemical nano-immunosensing of effective cardiac biomarkers for acute myocardial infarction

2013

Abstract This review provides an overview of the various types of electrochemical immunosensors that have been developed for determination of cardiac biomarkers, along with significant advances over the last several years in related technologies. We also summarize the latest developments in the applications of electrochemical immunosensors in ultrasensitive detection of electroactive cardiac biomarkers.

medicine.medical_specialtyHeart diseasebiologyCardiac biomarkersbusiness.industrymedicine.diseaseTroponinAnalytical Chemistrychemistry.chemical_compoundMyoglobinchemistryInternal medicinemedicineCardiologybiology.proteinMyocardial infarctionbusinessSpectroscopyTrAC Trends in Analytical Chemistry
researchProduct